Cargando…

Acute asthma management during SARS-CoV2-pandemic 2020

BACKGROUND: The current COVID-19 pandemic has changed many medical practices in order to provide additional protection to both our patients and healthcare providers. In many cases this includes seeing patients through electronic means such as telehealth or telephone rather than seeing them in person...

Descripción completa

Detalles Bibliográficos
Autores principales:	Levin, Michael, Ansotegui, Ignacio J., Bernstein, Jonathan, Chang, Yoon-Seok, Chikhladze, Manana, Ebisawa, Motohiro, Fiocchi, Alessandro, Heffler, Enrico, Martin, Bryan, Morais-Almeida, Mario, Papadopoulos, Nikolaos G., Peden, David, Wong, Gary W.K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	World Allergy Organization 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7221365/ https://www.ncbi.nlm.nih.gov/pubmed/32411315 http://dx.doi.org/10.1016/j.waojou.2020.100125

Ejemplares similares

COVID-19, asthma, and biological therapies: What we need to know
por: Morais-Almeida, Mário, et al.
Publicado: (2020)

Allergy and coronavirus disease (COVID-19) international survey: Real-life data from the allergy community during the pandemic
por: Tanno, Luciana Kase, et al.
Publicado: (2021)

The challenges of chronic urticaria part 1: Epidemiology, immunopathogenesis, comorbidities, quality of life, and management()
por: Sánchez-Borges, Mario, et al.
Publicado: (2021)

The challenges of chronic urticaria part 2: Pharmacological treatment, chronic inducible urticaria, urticaria in special situations()
por: Sánchez-Borges, Mario, et al.
Publicado: (2021)

WAO-ARIA consensus on chronic cough - Part II: Phenotypes and mechanisms of abnormal cough presentation — Updates inCOVID-19()
por: Rouadi, Philip W., et al.
Publicado: (2021)

WAO-ARIA consensus on chronic cough – Part 1: Role of TRP channels in neurogenic inflammation of cough neuronal pathways()
por: Rouadi, Philip W., et al.
Publicado: (2021)

WAO-ARIA consensus on chronic cough – Part III: Management strategies in primary and cough-specialty care. Updates inCOVID-19
por: Rouadi, Philip W., et al.
Publicado: (2022)

Skin as an immune organ and clinical applications of skin-based immunotherapy
por: Bird, J. Andrew, et al.
Publicado: (2018)

225 Monitoring of Air-Pollutants Concentration in Children with Allergic Diseases
por: Chikhladze, Manana V., et al.
Publicado: (2012)

World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) Guidelines update – I – Plan and definitions
por: Fiocchi, Alessandro, et al.
Publicado: (2022)

Challenges and choices in the pharmacological treatment of non-severe pediatric asthma: A commentary for the practicing physician()
por: Kalayci, Omer, et al.
Publicado: (2019)

World allergy organization anaphylaxis guidance 2020
por: Cardona, Victoria, et al.
Publicado: (2020)

Off-label prescribing for allergic diseases in children
por: Silva, Diana, et al.
Publicado: (2014)

Biologics and global burden of asthma: A worldwide portrait and a call for action
por: Caminati, M., et al.
Publicado: (2021)

Budesonide inhalation suspension versus methylprednisolone for treatment of moderate bronchial asthma attacks
por: Yanagida, Noriyuki, et al.
Publicado: (2015)

Environmental Exposure and Genetic Predisposition as Risk Factors for Asthma in China
por: Chen, Yan, et al.
Publicado: (2016)

Personalized Approach to Severe Asthma
por: Heffler, Enrico, et al.
Publicado: (2018)

Insights into urticaria in pediatric and adult populations and its management with fexofenadine hydrochloride
por: Ansotegui, Ignacio J., et al.
Publicado: (2022)

Correction to: Insights into urticaria in pediatric and adult populations and its management with fexofenadine hydrochloride
por: Ansotegui, Ignacio J., et al.
Publicado: (2022)

Otitis media with effusion and atopy: is there a causal relationship?
por: Zernotti, Mario E., et al.
Publicado: (2017)

31 Nasal Nitric Oxide and Nasal Polyposis as Determinants of Asthma Control
por: Heffler, Enrico, et al.
Publicado: (2012)

Anaphylaxis and COVID-19 vaccines: Real-time interest using Google Trends()
por: Camacho, Bernardo, et al.
Publicado: (2021)

Interleukin-5 in the Pathophysiology of Severe Asthma
por: Pelaia, Corrado, et al.
Publicado: (2019)

Consensus on DEfinition of Food Allergy SEverity (DEFASE): Protocol for a systematic review
por: Arasi, Stefania, et al.
Publicado: (2020)

Consensus on DEfinition of Food Allergy SEverity (DEFASE) an integrated mixed methods systematic review
por: Arasi, Stefania, et al.
Publicado: (2021)

Aberrant Expression of Novel Cytokine IL-38 and Regulatory T Lymphocytes in Childhood Asthma
por: Chu, Man, et al.
Publicado: (2016)

Environmental contributions to the interactions of COVID-19 and asthma: A secondary publication and update
por: Urrutia-Pereira, Marilyn, et al.
Publicado: (2022)

Manifesto on small airway involvement and management in asthma and chronic obstructive pulmonary disease: an Interasma (Global Asthma Association - GAA) and World Allergy Organization (WAO) document endorsed by Allergic Rhinitis and its Impact on Asthma (ARIA) and Global Allergy and Asthma European Network (GA(2)LEN)
por: Braido, F., et al.
Publicado: (2016)

Manifesto on small airway involvement and management in asthma and chronic obstructive pulmonary disease: an Interasma (Global Asthma Association - GAA) and World Allergy Organization (WAO) document endorsed by Allergic Rhinitis and its Impact on Asthma (ARIA) and Global Allergy and Asthma European Network (GA(2)LEN)
por: Braido, F., et al.
Publicado: (2019)

The Intriguing Role of Interleukin 13 in the Pathophysiology of Asthma
por: Marone, Giancarlo, et al.
Publicado: (2019)

Itraconazole as “bridge therapy” to anti-IgE in patients with severe asthma with fungal sensitization
por: Pizzimenti, Stefano, et al.
Publicado: (2013)

Chronic Urticaria: The Need for Improved Definition
por: Gómez, R. Maximiliano, et al.
Publicado: (2022)

Current and Optimal Practices in Childhood Asthma Monitoring Among Multiple International Stakeholders
por: Papadopoulos, Nikolaos G., et al.
Publicado: (2023)

Effectiveness of omalizumab in patients with severe allergic asthma with and without chronic rhinosinusitis with nasal polyps: a PROXIMA study post hoc analysis
por: Heffler, Enrico, et al.
Publicado: (2020)

Pollutants and asthma: role of air toxics.
por: Peden, David B
Publicado: (2002)

The global impact of the DRACMA guidelines cow’s milk allergy clinical practice
por: Fiocchi, Alessandro, et al.
Publicado: (2018)

Multiplex Molecular Detection of Respiratory Pathogens in Children With Asthma Exacerbation
por: Leung, Ting Fan, et al.
Publicado: (2010)

Precautionary labelling of foods for allergen content: are we ready for a global framework?
por: Allen, Katrina J, et al.
Publicado: (2014)

Patient and physician perspectives on biological treatment in severe asthma: a Severe Asthma Network Italy survey
por: Crimi, Claudia, et al.
Publicado: (2023)

World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow’s Milk Allergy (DRACMA) Guideline update – XIV – Recommendations on CMA immunotherapy
por: Brozek, Jan L., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_35ibl80hlagegitfb9940k6qan